Insilico trial data suggests anti-aging properties for experimental drug
Insilico said trial data for an experimental drug to treat an age-related lung disease suggests it could have anti-aging properties, supporting hopes for other AI-discovered therapies.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.